
Title(s):
Associate Professor of Medicine
Appointment Phone:
410-955-3142
Primary Location:
The Johns Hopkins Hospital
Expertise:
Anemias, General Internal Medicine, Hypercoagulable States, Myeloproliferative Disorders, Thrombocytopenias
Education and Experience
Training
- SUNY at Buffalo School of Medicine (Buffalo NY)/ (1989)
Residencies
- Johns Hopkins Bayview Medical Center (Baltimore MD)/ Internal Medicine (1992)
Fellowships
- The Johns Hopkins Hospital (Baltimore MD)/ Hematology (1998)
Certifications
- Hematology, American Board of Internal Medicine (2006)
- Internal Medicine, American Board of Internal Medicine (2006)
Locations
The Johns Hopkins Hospital
600 N. Wolfe Street
Hospital Main Entrance - Sheikh Zayed Tower
Baltimore, MD 21287
Appointment Phone: 410-955-3142
Location Map
Department / Division
-
Medicine - Hematology
Centers/Institutes
Bio
Expertise
- Anemias
- General Internal Medicine
- Hypercoagulable States
- Myeloproliferative Disorders
- Thrombocytopenias
Research
Research and Publications
Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New Engl J Med 338:572-580, 1998.
Moliterno AR, Siebel K, Sun A, Hankins WD, Spivak JL. A novel thrombopoietin signaling defect in polycythemia vera platelets. Stem Cells 16(suppl 2):185-192, 1998.
Moliterno AR, Spivak JL. Post-translational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94:2555-2561, 1999.
Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll R, Spivak JL. Mpl Baltimore: A Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11444-7.
Goerttler PS, Mrz E, Johansson PL, Andreasson B, Kutti J, Moliterno AR, Marchioli R, Spivak JL, Pahl HL* for the MPD Research Consortium. Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels. Haematologica 2005;90:851-853
Segal J, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Ann Epidemiol. 2006 Feb;16(2):123-30
Moliterno AR, Williams D, Rogers O, Spivak JL. Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between Quantitative JAK2 V617F and Mpl Expression. Blood. 2006 Dec 1;108(12):3913-5.
Pemmaraju N, Moliterno AR, Williams D, Rogers O, Spivak JL. Quantitative JAK2 V617F Neutrophil Allele Burden Does Not Correlate with Thrombotic Risk in Essential Thrombocytosis. Leukemia 2007 Oct;21(10):2210-2.
Williams DR, Kim AH, Rogers O, Spivak JL, Moliterno AR. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis and idiopathic myelofibrosis. Exp Hematol. 2007 Nov;35(11):1641-6.
Moliterno AR, Williams D, Rogers O, Isaacs MA, Spivak JL Phenotypic variability within the JAK2 V617F-positive MPD: The roles of progenitor cell and neutrophil allele burdens. Exp Hematol. 2008 Nov;36(11):1480-6.
Moliterno AR, Siebel K, Sun A, Hankins WD, Spivak JL. A novel thrombopoietin signaling defect in polycythemia vera platelets. Stem Cells 16(suppl 2):185-192, 1998.
Moliterno AR, Spivak JL. Post-translational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94:2555-2561, 1999.
Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll R, Spivak JL. Mpl Baltimore: A Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11444-7.
Goerttler PS, Mrz E, Johansson PL, Andreasson B, Kutti J, Moliterno AR, Marchioli R, Spivak JL, Pahl HL* for the MPD Research Consortium. Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels. Haematologica 2005;90:851-853
Segal J, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Ann Epidemiol. 2006 Feb;16(2):123-30
Moliterno AR, Williams D, Rogers O, Spivak JL. Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between Quantitative JAK2 V617F and Mpl Expression. Blood. 2006 Dec 1;108(12):3913-5.
Pemmaraju N, Moliterno AR, Williams D, Rogers O, Spivak JL. Quantitative JAK2 V617F Neutrophil Allele Burden Does Not Correlate with Thrombotic Risk in Essential Thrombocytosis. Leukemia 2007 Oct;21(10):2210-2.
Williams DR, Kim AH, Rogers O, Spivak JL, Moliterno AR. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis and idiopathic myelofibrosis. Exp Hematol. 2007 Nov;35(11):1641-6.
Moliterno AR, Williams D, Rogers O, Isaacs MA, Spivak JL Phenotypic variability within the JAK2 V617F-positive MPD: The roles of progenitor cell and neutrophil allele burdens. Exp Hematol. 2008 Nov;36(11):1480-6.
Research Interests
- Molecular pathogenesis of myeloproliferative disorders
More Info
Languages
- English
Clinical Trials
- Polycythemia vera
Additional Resources

